Activated AKT phosphorylates RUNX2

Stable Identifier
R-HSA-8939963
Type
Reaction
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

Activated AKT phosphorylates RUNX2 without affecting its association with CBFB or its nuclear localization. Based on studies using recombinant mouse Runx2, the most prominent AKT target sites in human RUNX2 are inferred to be serine residue S196 and threonine residues T198 and T200. These sites are evolutionarily conserved and match S203, T205 and T207 of the recombinant mouse Runx2 (Pande et al. 2013). In addition to phosphorylating RUNX2, which increases its affinity for some target promoters (Pande et al. 2013), AKT signaling also stabilizes RUNX2 protein. Increased AKT signaling, achieved by knocking down PTEN, a negative regulator of AKT activation, reduces RUNX2 protein degradation, which possibly involves AKT-mediated nuclear exclusion of transcription factors FOXO1 and FOXO3. Increased RUNX2 activity in response to AKT signaling is implicated in vascular calcification, a pathological feature of atherosclerosis, diabetes mellitus and renal disease (Deng et al. 2015).

Literature References
PubMed ID Title Journal Year
23389849 Oncogenic cooperation between PI3K/Akt signaling and transcription factor Runx2 promotes the invasive properties of metastatic breast cancer cells

Pande, S, Browne, G, Padmanabhan, S, Zaidi, SK, Lian, JB, van Wijnen, AJ, Stein, JL, Stein, GS

J. Cell. Physiol. 2013
Participants
Participant Of
Catalyst Activity
Catalyst Activity
Title
protein serine/threonine kinase activity of p-T,p-S-AKT [nucleoplasm]
Physical Entity
Activity
Inferred From
Authored
Reviewed
Created